Matches in SemOpenAlex for { <https://semopenalex.org/work/W2247134373> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2247134373 endingPage "2552" @default.
- W2247134373 startingPage "2552" @default.
- W2247134373 abstract "2552 Background: Cancer patients are at increased risk for VTE as compared to the general population, making VTE as a sADR difficult to detect in the oncology setting. In 2004, two phase III trials identified higher mortality rates among epo-treated cancer patients who were receiving chemotherapy in “off-label” settings- with these studies identifying higher VTE rates in the treatment arms. We reviewed data on epo/darb-associated VTE in the oncology setting. Methods: Data sources were meta-analyses and the FDA’s MedWatch database. Results: Since 1996, only 259 VTE reports (darb: n=30, epo: n=229) of VTE in the setting of chemotherapy and epo/darb were reported to MedWatch. Meta-analyses findings are tabulated below: Conclusions: In 2004, package inserts for Epo/Darb were revised, identifying increased risks of VTE with these agents in the oncology setting. Identification of this adverse drug reaction thirteen years after Epo received FDA approval for this indication (and had been prescribed to > 500,000 cancer patients) illustrates difficulties inherent with current pharmacovigilance efforts. [Table: see text] No significant financial relationships to disclose." @default.
- W2247134373 created "2016-06-24" @default.
- W2247134373 creator A5004158872 @default.
- W2247134373 creator A5010105777 @default.
- W2247134373 creator A5014669541 @default.
- W2247134373 creator A5035662168 @default.
- W2247134373 creator A5037456539 @default.
- W2247134373 creator A5043859344 @default.
- W2247134373 creator A5064538625 @default.
- W2247134373 creator A5067434226 @default.
- W2247134373 creator A5071586004 @default.
- W2247134373 date "2007-06-20" @default.
- W2247134373 modified "2023-10-14" @default.
- W2247134373 title "Recombinant erythropoietin (Epo)/darbepoetin (Darb) associated venous thromboembolism (VTE) in the oncology setting: Findings from the Research on Adverse Drug Events And Reports (RADAR) project" @default.
- W2247134373 doi "https://doi.org/10.1200/jco.2007.25.18_suppl.2552" @default.
- W2247134373 hasPublicationYear "2007" @default.
- W2247134373 type Work @default.
- W2247134373 sameAs 2247134373 @default.
- W2247134373 citedByCount "5" @default.
- W2247134373 countsByYear W22471343732013 @default.
- W2247134373 countsByYear W22471343732022 @default.
- W2247134373 countsByYear W22471343732023 @default.
- W2247134373 crossrefType "journal-article" @default.
- W2247134373 hasAuthorship W2247134373A5004158872 @default.
- W2247134373 hasAuthorship W2247134373A5010105777 @default.
- W2247134373 hasAuthorship W2247134373A5014669541 @default.
- W2247134373 hasAuthorship W2247134373A5035662168 @default.
- W2247134373 hasAuthorship W2247134373A5037456539 @default.
- W2247134373 hasAuthorship W2247134373A5043859344 @default.
- W2247134373 hasAuthorship W2247134373A5064538625 @default.
- W2247134373 hasAuthorship W2247134373A5067434226 @default.
- W2247134373 hasAuthorship W2247134373A5071586004 @default.
- W2247134373 hasConcept C121608353 @default.
- W2247134373 hasConcept C126322002 @default.
- W2247134373 hasConcept C143998085 @default.
- W2247134373 hasConcept C177713679 @default.
- W2247134373 hasConcept C197934379 @default.
- W2247134373 hasConcept C2781404941 @default.
- W2247134373 hasConcept C2908647359 @default.
- W2247134373 hasConcept C535046627 @default.
- W2247134373 hasConcept C57658597 @default.
- W2247134373 hasConcept C71924100 @default.
- W2247134373 hasConcept C99454951 @default.
- W2247134373 hasConceptScore W2247134373C121608353 @default.
- W2247134373 hasConceptScore W2247134373C126322002 @default.
- W2247134373 hasConceptScore W2247134373C143998085 @default.
- W2247134373 hasConceptScore W2247134373C177713679 @default.
- W2247134373 hasConceptScore W2247134373C197934379 @default.
- W2247134373 hasConceptScore W2247134373C2781404941 @default.
- W2247134373 hasConceptScore W2247134373C2908647359 @default.
- W2247134373 hasConceptScore W2247134373C535046627 @default.
- W2247134373 hasConceptScore W2247134373C57658597 @default.
- W2247134373 hasConceptScore W2247134373C71924100 @default.
- W2247134373 hasConceptScore W2247134373C99454951 @default.
- W2247134373 hasIssue "18_suppl" @default.
- W2247134373 hasLocation W22471343731 @default.
- W2247134373 hasOpenAccess W2247134373 @default.
- W2247134373 hasPrimaryLocation W22471343731 @default.
- W2247134373 hasRelatedWork W2004689515 @default.
- W2247134373 hasRelatedWork W2183235718 @default.
- W2247134373 hasRelatedWork W2393963628 @default.
- W2247134373 hasRelatedWork W2417474369 @default.
- W2247134373 hasRelatedWork W2464759024 @default.
- W2247134373 hasRelatedWork W2518309888 @default.
- W2247134373 hasRelatedWork W2541980554 @default.
- W2247134373 hasRelatedWork W3177567484 @default.
- W2247134373 hasRelatedWork W3210538327 @default.
- W2247134373 hasRelatedWork W4299555276 @default.
- W2247134373 hasVolume "25" @default.
- W2247134373 isParatext "false" @default.
- W2247134373 isRetracted "false" @default.
- W2247134373 magId "2247134373" @default.
- W2247134373 workType "article" @default.